DUBLIN, Ireland, December 22, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT), a worldwide leader in healthcare technology, said today that the Centers for Medicare & Medicaid Services (CMS) in the United States would extend Medicare coverage for all kinds of continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs.